In bronchiectasis, poor physical capacity correlates with poor quality of life
- PMID: 35800900
- PMCID: PMC9255225
- DOI: 10.1080/20018525.2022.2095104
In bronchiectasis, poor physical capacity correlates with poor quality of life
Abstract
Purpose: Patients with bronchiectasis (BE) who suffer frequent exacerbations are likely to experience negative effects on quality of life (QoL) and require more healthcare utilization. We aimed to discover, in a cohort of Finnish BE patients, those risk factors that influence QoL.
Methods: Non-cystic fibrosis BE patients of a Helsinki University Hospital cohort were examined with high-resolution computed tomography (HRCT) of the chest. They completed a disease-specific quality of life-bronchiectasis (QoL-B) questionnaire in Finnish translation. We considered scores in the lowest quarter (25%) of that QoL-B scale to indicate poor QoL. The bronchiectasis severity index (BSI), FACED score, and modified Medical Research Council (mMRC) dyspnoea scale were used.
Results: Overall, of 95 adult BE patients, mean age was 69 (SD ± 13) and 79% were women. From the cohort, 82% presented with chronic sputum production and exacerbations, at a median rate of 1.7 (SD ± 1.6). The number of exacerbations (OR 1.7), frequent exacerbations (≥3 per year) (OR 4.9), high BSI score (OR 1.3), and extensive disease (≥3 lobes) (OR 3.7) were all predictive of poor QoL. Frequent exacerbations were associated with bronchial bacterial colonisation, low forced expiratory volume in 1 s (FEV1), and radiological disease severity. Based on the BSI, 34.1% of our cohort had severe disease, with 11.6% classified as severe according to their FACED score. The mMRC dyspnoea score (r = -0.57) and BSI (r = -0.60) correlated, in the QoL-B questionnaire, negatively with physical domain.
Conclusion: The strongest determinants of poor QoL in the cohort of Finnish BE patients were frequent exacerbations, radiological disease severity, and high BSI score. Neither comorbidities nor BE aetiology appeared to affect QoL. Reduced physical capacity correlated with dyspnoea and severe disease.
Study registration: University of Helsinki, Faculty of Medicine, 148/16.08.2017.
Keywords: Bronchiectasis; bronchiectasis severity index; exacerbation; extensive disease; quality of life.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
In relation to this study, the authors declare that there are no conflicts of interest.
Similar articles
-
Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.Expert Rev Respir Med. 2018 Sep;12(9):769-782. doi: 10.1080/17476348.2018.1503540. Epub 2018 Aug 3. Expert Rev Respir Med. 2018. PMID: 30025482 Review.
-
Aetiology and disease severity are among the determinants of quality of life in bronchiectasis.Clin Respir J. 2019 Aug;13(8):521-529. doi: 10.1111/crj.13054. Epub 2019 Jul 24. Clin Respir J. 2019. PMID: 31295770
-
The Bronchiectasis Severity Index and FACED score for assessment of the severity of bronchiectasis.Pulmonology. 2018 May/June;24(3):149-154. doi: 10.1016/j.rppnen.2017.08.009. Epub 2018 Jan 3. Pulmonology. 2018. PMID: 29306672
-
Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:761-769. doi: 10.2147/COPD.S139776. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29535516 Free PMC article.
-
Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies.BMJ Evid Based Med. 2018 Jun;23(3):96-103. doi: 10.1136/bmjebm-2018-110893. Epub 2018 Apr 20. BMJ Evid Based Med. 2018. PMID: 29678900
Cited by
-
Risk factors for mortality in Finnish bronchiectasis patients: A four-year study.Chron Respir Dis. 2025 Jan-Dec;22:14799731251358596. doi: 10.1177/14799731251358596. Epub 2025 Aug 17. Chron Respir Dis. 2025. PMID: 40820309 Free PMC article.
-
Health-Related Quality of Life and Stress-Related Disorders in Patients with Bronchiectasis after Pulmonary Resection.J Pers Med. 2023 Aug 26;13(9):1310. doi: 10.3390/jpm13091310. J Pers Med. 2023. PMID: 37763078 Free PMC article.
-
Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.Eur Respir Rev. 2024 Oct 30;33(174):240087. doi: 10.1183/16000617.0087-2024. Print 2024 Oct. Eur Respir Rev. 2024. PMID: 39477356 Free PMC article. Review.
-
Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study.BMJ Open Respir Res. 2023 Nov 27;10(1):e001517. doi: 10.1136/bmjresp-2022-001517. BMJ Open Respir Res. 2023. PMID: 38016706 Free PMC article.
-
Cough in non-cystic fibrosis bronchiectasis.ERJ Open Res. 2024 Dec 2;10(6):00330-2024. doi: 10.1183/23120541.00330-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39624376 Free PMC article.
References
-
- Lee AL, Button BM, Ellis S, et al. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med. 2009;103(5):780–7. - PubMed
-
- Eshed I, Minski I, Katz R, et al. Bronchiectasis: correlation of high-resolution CT findings with health-related quality of life. Clin Radiol. 2007;62(2):152–159. - PubMed
-
- Wilson CB, Jones PW, O’leary CJ, et al. Validation of the St. George’s Respiratory Questionnaire in Bronchiectasis. Am J Respir Crit Care Med. 1997;156(2):536–541. - PubMed
-
- Murray MP, Turnbull K, MacQuarrie S, et al. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009;34(1):125–131. - PubMed
LinkOut - more resources
Full Text Sources